mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland.
Intensive Care Med
; 48(3): 362-365, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35050384
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Type of study:
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Intensive Care Med
Year:
2022
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United States